On 23 March 2026, the Second Annual Meeting of the Understanding Tumour-Host Interactions Cluster (U-THI Cluster) took place at the Nencki Institute of Experimental Biology, Polish Academy of Sciences, in Warsaw, Poland. Hosted by the HIT-GLIO project in a hybrid format, the meeting brought together representatives from across the cluster to exchange scientific progress, discuss shared challenges, and identify opportunities for further collaboration. The U-THI Cluster brings

Following the MULTIR Hybrid Symposium on 2 October 2025 in Hannover and online, we invited Rob White of Melanoma Patient Network Europe (MPNE), who chaired the closing panel discussion, to share his reflections on some of the questions raised during the event. While the symposium brought together clinicians, researchers, AI experts, industry, ethicists and patient advocates to explore how AI can transform cancer care, this conversation focuses specifically on what stayed with

On 4 December, the MULTIR project participated in the EU Cancer Mission Conference in Copenhagen, held under the framework of the EU Mission on Cancer. The project was represented by Prof. Harald Mischak (MOS) , who presented MULTIR’s work and its contribution to tackling the clinical challenge of variable patient responses to immunotherapy. His presentation emphasized the critical role of understanding tumour-host immune interactions in influencing treatment outcomes. The